(Q40639774)

22 September 2017

title

Anti-angiogenic effect of silymarin on colon cancer LoVo cell line (English)

1 reference

22 September 2017

main subject

angiogenesis inhibitor

1 reference

1 reference

Shung-Haur Yang

1

1 reference

22 September 2017

Jen-Kou Lin

series ordinal

2

1 reference

22 September 2017

Wei-Shone Chen

series ordinal

3

1 reference

22 September 2017

Jen-Hwey Chiu

series ordinal

4

1 reference

22 September 2017

publication date

1 July 2003

1 reference

Journal of Surgical Research

22 September 2017

published in

1 reference

22 September 2017

volume

113

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

133-138

1 reference

Tumor angiogenesis: therapeutic implications

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

The prognostic significance of tumor vascularization in patients with localized colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Vascular endothelial growth factor (VEGF) and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Clinical applications of angiogenic growth factors and their inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Protective effects of silymarin against photocarcinogenesis in a mouse skin model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Permanent cell line expressing human factor VIII-related antigen established by hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Antiangiogenic therapy in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Thalidomide: emerging role in cancer medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

Theoretical basis for the activity of thalidomide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900229-4

10.1016/S0022-4804(03)00229-4

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference